MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 131 filers reported holding MIRATI THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $716,000 | -72.2% | 9,186 | -63.2% | 0.35% | -68.2% |
| Q2 2019 | $2,573,000 | +21.1% | 24,981 | -13.8% | 1.09% | +16.3% |
| Q1 2019 | $2,125,000 | +85.9% | 28,991 | +19.5% | 0.94% | +103.2% |
| Q3 2018 | $1,143,000 | -20.3% | 24,260 | -16.6% | 0.46% | -34.0% |
| Q2 2018 | $1,435,000 | +28.7% | 29,099 | -19.9% | 0.70% | +21.3% |
| Q1 2018 | $1,115,000 | – | 36,335 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |